logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Current Hematologic Malignancy Reports cover

Current Hematologic Malignancy Reports

IF3.3
Papers57
Citations1303
Journal Papers 57
Publication Date
delete
FLT3-Mutated AML: Transplanting with Precision in the Targeted Era
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-10-01
delete0
PREAI
deleteJoseph F. Mort; Alex J. Ambinder
deleteShare
deleteSave
Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-09-18
delete0
deleteOAAI
deleteGhaith Abu-Zeinah; Gabriela S. Hobbs; Raajit K. Rampal; Sung-Eun Lee; Harinder Gill; Rami Komrokji; Tsewang Tashi; Prithviraj Bose; John Mascarenhas; Abdulraheem Yacoub; Stephen T. Oh; Kazuya Shimoda; Brandi N. Reeves; Minghui Duan; Lennex Hsueh-Lin Yu; Albert Qin; Josef T. Prchal; Kenneth Kaushansky; Ruben A. Mesa
deleteShare
deleteSave
Strategies to Overcome Inequities in the Treatment of Patients with Hematologic Malignancies
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-09-11
delete0
PREAI
deleteCarlos de la Cruz-de la Cruz; Yessica M. González-Mártinez; Andrés Gómez-De León
deleteShare
deleteSave
Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-29
delete0
PREAI
deleteNaveen Subramanian; Samuel M. Rubinstein
deleteShare
deleteSave
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-11
delete0
deleteOAAI
deleteHamsa Murli; Sadia Alam; Evelyn Mesler; Aditi Shastri
deleteShare
deleteSave
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteJulio Alvarenga Thiebaud; Tamer Othman; Ibrahim Aldoss
deleteShare
deleteSave
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteElisa Hofmeister; Ajay Major
deleteShare
deleteSave
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-03
delete0
deleteOAAI
deleteSanam Loghavi; Robert P. Hasserjian
deleteShare
deleteSave
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-13
delete0
deleteOAAI
deleteLiesl S. Eibschutz; Samuel Crow; Caroline Tatum; Daniel Reed; Michael Keng
deleteShare
deleteSave
Correction: Clonal Signatures of Telomere Biology Disorders
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-10
delete0
PREAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
deleteShare
deleteSave
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-05-01
delete0
deleteOAAI
deleteAbdulrahman Al-Abdulmalek; Eric Landry; Mohammed Abdulgayoom; Abdulrahman F. Al-Mashdali; Ayman Abdullah Dalol; Bassam Muthanna; Jean-Pierre Routy; Shehab F. Mohamed
deleteShare
deleteSave
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-25
delete0
PREAI
deleteZuhal Naderi; Teresa Sadras; Susan Branford; Naranie Shanmuganathan; Ilaria S. Pagani
deleteShare
deleteSave
Germline DDX41 Variants: Current Understanding and Future Directions
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-23
delete0
PREAI
deleteAldo A. Acosta-Medina; Abhishek A. Mangaonkar
deleteShare
deleteSave
Clonal Signatures of Telomere Biology Disorders
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-14
delete0
deleteOAAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
deleteShare
deleteSave
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-07
delete0
deleteOAAI
deleteColette Hanna; Joe Rizkallah; Nicole Charbel; Shereen Sakkal; Fadi G. Haddad
deleteShare
deleteSave
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-06
delete0
deleteOAAI
deleteAngela G Fleischman
deleteShare
deleteSave
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-26
delete0
deleteOAAI
deleteSamon Benrashid; Jennifer A. Woyach
deleteShare
deleteSave
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World Applications
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-24
delete0
deleteOAAI
deleteValerie Tran; Nandan Srinivasa; Caroline Tatum; Daniel Reed; Michael Keng
deleteShare
deleteSave
New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-14
delete0
PREAI
deleteBhavesh Mohan Lal; Shaji K. Kumar
deleteShare
deleteSave
The Role and Impact of Non-driver Gene Mutations in Myelofibrosis
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-10
delete0
deleteOAAI
deleteValentina Boldrini; Paola Guglielmelli; Alessandro M. Vannucchi
deleteShare
deleteSave